We are live on ! Find out more
Two Sigma Investments

Two Sigma Investments Portfolio holdings

AUM $124B
1-Year Est. Return 33.93%
This Fund
S&P 500
This Quarter Est. Return
-16.78%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.83%
AUM
$25.5B
AUM Growth
-$11.1B
Cap. Flow
-$5.25B
Cap. Flow %
-20.57%
Top 10 Hldgs %
6.83%
Holding
3,851
New
730
Increased
952
Reduced
1,216
Closed
943

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.44%
2 Technology 14.21%
3 Industrials 12.1%
4 Healthcare 9.72%
5 Financials 6.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFSW
2751
DELISTED
PFSweb, Inc.
PFSW
$164K ﹤0.01%
32,041
-18,983
-37% -$122K
ORBC
2752
DELISTED
ORBCOMM, Inc.
ORBC
$164K ﹤0.01%
19,800
-150,227
-88% -$1.4M
FRST icon
2753
Primis Financial Corp
FRST
$408M
$163K ﹤0.01%
+12,359
New +$186K
TDAY
2754
USA Today Co
TDAY
$1.27B
$163K ﹤0.01%
+14,105
New +$197K
CETV
2755
DELISTED
Central European Media Enterprises Ltd
CETV
$162K ﹤0.01%
58,242
-8,788
-13% -$28.9K
CTIC
2756
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$161K ﹤0.01%
219,569
+10,759
+5% +$17.7K
RDFN
2757
CALL
DELISTED
Redfin
RDFN
$160K ﹤0.01%
11,100
+100
+0.9% +$1.59K
SMFG icon
2758
Sumitomo Mitsui Financial
SMFG
$162B
$160K ﹤0.01%
24,607
-42,783
-63% -$319K
DHT icon
2759
DHT Holdings
DHT
$2.89B
$159K ﹤0.01%
+40,617
New +$188K
PVLA
2760
Palvella Therapeutics
PVLA
$2.18B
$159K ﹤0.01%
+749
New +$232K
TTOO
2761
DELISTED
T2 Biosystems, Inc
TTOO
$157K ﹤0.01%
10
+2
+25% +$47K
INSY
2762
DELISTED
Insys Therapeutics, Inc.
INSY
$156K ﹤0.01%
+44,700
New +$311K
GECC icon
2763
Great Elm Capital Corp
GECC
$72.5M
$155K ﹤0.01%
+3,285
New +$167K
VWTR
2764
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
$153K ﹤0.01%
16,776
-52,710
-76% -$557K
CBIO
2765
Crescent Biopharma
CBIO
$587M
$152K ﹤0.01%
+161
New +$194K
CLD
2766
DELISTED
Cloud Peak Energy Inc
CLD
$151K ﹤0.01%
+411,666
New +$586K
SNNA
2767
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$149K ﹤0.01%
+64,074
New +$565K
BCRX icon
2768
BioCryst Pharmaceuticals
BCRX
$2.31B
$145K ﹤0.01%
18,000
-130,649
-88% -$1.02M
EPRT icon
2769
Essential Properties Realty Trust
EPRT
$6.61B
$145K ﹤0.01%
10,485
-57,139
-84% -$794K
HPE icon
2770
PUT
Hewlett Packard
HPE
$72.2B
$145K ﹤0.01%
11,000
-1,300
-11% -$19.5K
RVSB icon
2771
Riverview Bancorp
RVSB
$109M
$145K ﹤0.01%
19,866
-14,309
-42% -$115K
FLEX icon
2772
PUT
Flex
FLEX
$46.4B
$143K ﹤0.01%
+24,948
New +$174K
AZRE
2773
DELISTED
Azure Power Global Limited
AZRE
$140K ﹤0.01%
15,497
-12,354
-44% -$138K
EARN
2774
Ellington Residential Mortgage REIT
EARN
$161M
$139K ﹤0.01%
13,620
-6,229
-31% -$67.4K
HTZ
2775
PUT
DELISTED
Hertz Global Holdings, Inc.
HTZ
$139K ﹤0.01%
11,740
-8,633
-42% -$121K

Similar funds

Two Sigma Investments's Q4 2018 Portfolio in Review

As of Q4 2018, Two Sigma Investments held 3,851 positions worth $25.5B, down 30% from $36.7B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.

Two Sigma Investments withdrew a net $5.25B in Q4 2018, closing 943 positions and reducing 1,216 holdings. Its most notable exit was Elevance Health, an estimated $180M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.

Against the trend, Two Sigma Investments opened a new position in Starbucks worth $176M.

  • Two Sigma Investments's largest Q4 2018 buy was Starbucks: 2,727,875 shares worth $176M.
  • Two Sigma Investments added most to SLB Ltd in Q4 2018, an estimated $230M increase.
  • Two Sigma Investments's biggest Q4 2018 reduction was Procter & Gamble, cutting an estimated $185M.
  • Two Sigma Investments fully exited Elevance Health in Q4 2018, selling an estimated $180M.
  • Two Sigma Investments's ten largest holdings make up 6.8% of its $25.5B portfolio in Q4 2018.
  • Two Sigma Investments opened 730 new positions and closed 943 in Q4 2018.
  • Two Sigma Investments's portfolio value fell 30% quarter-over-quarter to $25.5B.

Based on Two Sigma Investments's 13F filing for Q4 2018, filed 14 Feb 2019.